Back to News
Market Impact: 0.2
CelluPro erhält EXCiPACT™-Zertifizierung für die Herstellung von Zellkulturmedien in GMP-Qualität und stärkt damit seine globalen Lieferkapazitäten im Bereich der biopharmazeutischen Produktion
Source: PR Newswire
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
CelluPro, a China-based biotechnology company specializing in serum-free cell-culture media and bioprocessing solutions, received EXCiPACT GMP certification for pharmaceutical excipients. The company said it is the first Chinese provider to obtain the certification, potentially strengthening its quality credentials and market positioning in pharmaceutical and bioprocess supply chains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
More News
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- PG&E’s CEO says AI is ‘the best thing that could’ve ever happened to the grid’
- Defense giant Saab sees orders triple after Gripen fighter jet deal with Ukraine
- Volvo Cars shares plunge 25% amid China sales slump and fresh job cuts
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%
- Eni Raises Investor Payouts as High Fuel Prices Boost Cash Flow